Oncogenic mutations of BRAF are the most common genetic events in melanomas [11] and papillary thyroid cancers (PTC) [12], [13], and are thought to be involved in early stages of tumor development, as they are present in benign nevi [14] and micropapillary thyroid cancers [15], respectively. This evidence concerns the gene BRAF and neoplasm.